Chief Executive

NO·Oslo Børs

Lytix Biopharma ASA

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

—

▼ Sales (0 ops.)

Explore the full record of transactions filed by Chief Executive. Insider active across 1 companies, notably Lytix Biopharma ASA. Cumulatively, 1 reports have been published. The latest transaction was filed on 11 December 2025 — Purchase. Regulator: Oslo Børs. The full history is openly available.

Declarations1 total

Executives●PurchaseLLytix Biopharma ASA0Oslo

C

Chief Executive

€8,47010,000 shares@ €0.847

ShareMERK

OSLO:661716·11 Dec 2025

Ideal exit: 7 Sept 2026 (T+270)

Oslo ↗

1 of 1 declaration